Because the doses of atorvastatin and rosuvastatin administered in the monkeys were equivalent to the highest ones for human use, including in homozygous FH patients, the LDLR KO monkeys were considered to be strongly resistant to statins. Here, LDLR is linked to familial hyperaldosteronism.